本文翻译正在准备中。在此之前，我们暂时显示英文原文。
商业 · 2002/5/231 分钟阅读
Determination That Ardeparin Sodium Injection Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness
本地自动翻译 · 来源原始语言
摘要
The Food and Drug Administration (FDA) has determined that ardeparin sodium injection (Normiflo) was not withdrawn from sale for reasons of safety or effectiveness. This determination will allow FDA to approve abbreviated new drug applications (ANDAs) for ardeparin sodium injection.
来源原始语言: Federal Register — Food and Drug Administration打开原始公告 →